Maravai LifeSciences
MRVI
MRVI
221 hedge funds and large institutions have $1.58B invested in Maravai LifeSciences in 2023 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 72 increasing their positions, 82 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $1.79B → $1.58B (-$213M)
12% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 82
78% less call options, than puts
Call options by funds: $2.72M | Put options by funds: $12.3M
Holders
221
Holding in Top 10
1
Calls
$2.72M
Puts
$12.3M
Top Buyers
| 1 | +$22.4M | |
| 2 | +$22M | |
| 3 | +$20.8M | |
| 4 |
RI
RTW Investments
New York
|
+$19.1M |
| 5 |
N
Natixis
Paris,
France
|
+$18.5M |
Top Sellers
| 1 | -$53.2M | |
| 2 | -$44.3M | |
| 3 | -$28.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$21.1M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$17.3M |